Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Debt / NOTE 1.500%10/1
-
Number of holders
-
0
-
Total 13F principal, excl. options
-
0
-
Principal change
-
-357,830,003
-
Total reported value, excl. options
-
$0
-
Value change
-
-$356,597,732
-
Number of sells
-
-31
Significant Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 as of Q4 2020
31 filings reported holding 09061GAF8 - BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 as of Q4 2020.
BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 has 0 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $0 of principal
.
Largest 10 bondholders include Sowell Financial Services LLC ($0 of principal), Daiwa Securities Group Inc. ($0 of principal), Russell Investments Group, Ltd. ($0 of principal), BANK OF AMERICA CORP /DE/ ($0 of principal), Invesco Ltd. ($0 of principal), CSS LLC/IL ($0 of principal), OAKTREE CAPITAL MANAGEMENT LP ($0 of principal), SONORA INVESTMENT MANAGEMENT, LLC ($0 of principal), CALAMOS ADVISORS LLC ($0 of principal), and Weaver Consulting Group ($0 of principal).
This table shows the top 0 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.